New England Peptide, a Massachusetts-based designer and producer of custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide, is providing customers with alternative chemical solutions in the face of the global shortage of acetonitrile. Heading New England Peptide's strategic usage of new solutions are two leading peptide experts, Dr. Robert Hammer and Dr. Robert Hodges.
Gardner, MA (PRWEB) January 9, 2009 -- New England Peptide, LLC (NEP) today announced its solutions to the worldwide shortage of acetonitrile, a critical chemical ingredient used in the purification and analysis of pharmaceutical and research grade peptides.
In recent months, NEP has added a globally-renowned peptide researcher, Dr. Robert Hodges, to its Scientific Advisory Board (SAB) and named a peptide chemistry expert, Dr. Robert Hammer, as its new Director of Chemical Development
Hammer and Hodges are leading NEP's efforts to implement measures to replace acetonitrile as a solvent in the high-performance liquid chromatography (HPLC) of peptides. HPLC is a commonly-used process in biochemistry and pharmaceutical chemistry to quantify the purity of compounds such as peptides and also to prepare pure compounds for research and pharmaceutical uses. In recent months, NEP has successfully purified hundreds of peptides using these alternative methods for customers across the globe.
"While the acetonitrile shortage is a challenge to the peptide industry, it also provides an opportunity to create a cost-effective solution to this global crisis," said NEP CEO Dave Robinson. "The additions of Dr. Hodges and Dr. Hammer to our expert team positions NEP to successfully pursue the use of alternative solvents."
Acetonitrile is a byproduct of the automotive industry that is the primary chemical solvent used in HPLC analysis and purification of pep
Copyright©2009 Vocus, Inc.
All rights reserved